Condition
Type 2 Diabetes
Locations
Hungary
Start date
30/09/2024
Identifiers
Trial ID
NN9924-7787,
NCT number NCT06269120,
Eudract number Not Available
NCT number NCT06269120,
Eudract number Not Available
Summary
Participant will get oral semaglutde as prescribed by the study doctor. The study will last for about 26 ± 4 weeks (5 to 7 months). Participant will be asked to complete a questionnaire about how they take oral semaglutide tablets during normal scheduled visit with doctor. Participant will also be asked questions about health and their diabetes treatment and lab tests as part of normal doctor's appointment.
Trial Overview:
Treatment
DRUG: Oral Semaglutide
Study type
OBSERVATIONAL
Trial duration
Sep 30 2024 - Sep 30 2025
Participants
470
Phase
Not Available
Are you eligible?
Gender
Male and female
Age
18 years and older
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.